Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice.
about
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathyRegenerative therapies for diabetic microangiopathyUsing basic fibroblast growth factor nanoliposome combined with ultrasound-introduced technology to early intervene the diabetic cardiomyopathy.Diabetic cardiomyopathy: where we are and where we are going.Trypanosoma cruzi coaxes cardiac fibroblasts into preventing cardiomyocyte death by activating nerve growth factor receptor TrkA.Performance and acceptability of a combined device for insulin infusion and glucose sensing in the home setting.Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.Cardiomyocyte GTP Cyclohydrolase 1 Protects the Heart Against Diabetic CardiomyopathyCardiac fibroblasts regulate sympathetic nerve sprouting and neurocardiac synapse stabilityAdvanced Interfere Treatment of Diabetic Cardiomyopathy Rats by aFGF-Loaded Heparin-Modified Microbubbles and UTMD Technique.Nerve growth factor: a neuroimmune crosstalk mediator for all seasons.Sex, sex steroids, and diabetic cardiomyopathy: making the case for experimental focus.Nerve growth factor: Does this have the potential to become a miraculous treatment for diabetic heart?Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart.Targeted delivery of human VEGF gene via complexes of magnetic nanoparticle-adenoviral vectors enhanced cardiac regeneration.Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction.Neurotrophin Signaling Is Required for Glucose-Induced Insulin Secretion.Activation of the NGF/TrkA signaling pathway attenuates diabetic erectile dysfunction.Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart.
P2860
Q26775037-59325056-CE80-4939-9203-CB212B6E491AQ27027852-26CE07BC-610E-49E1-8E9D-542808CB4788Q30389310-FA740358-6E01-46A8-9B56-7436EEA1EBF4Q33690717-5FFCE119-1AE9-48BC-B286-0047F42F7B0BQ34600541-A0820DF2-C24E-4CF1-98D4-34E9F1DE72C3Q36159086-80CECBD3-8A3C-4EA7-A732-67D08C972016Q36479405-434FA148-E9DB-4C1A-AF40-6C4206B39084Q36997215-F5146CE7-EA1B-4AF4-9A29-7DCDA55D6937Q37309358-EEEB8448-E263-4A40-8054-8A8F84F5C02AQ38899271-337DE816-ECD8-4FB7-91BA-7F9BB7E1D771Q39098815-A6DA5B19-42D0-4F4A-920C-46F749B98BD4Q39398383-56934D8D-649E-4AE8-B99E-907339075FBBQ39403735-26D47AA5-4F3E-4A49-9BEB-DDA1F0E003B4Q41021093-C3B4C082-C9F0-4ECE-85F8-4CC3009BCDF5Q41992397-FDD4A055-49F2-4EFE-AA3A-FA8B7B7EF7FBQ42241172-3E334C7F-B765-4D2D-8728-AB33018634FCQ43080783-4D5993B4-0700-4311-A0C0-0920890901FEQ47102909-1E0B0445-28BF-4659-8DB8-627EFE0CC859Q49384661-463ECD39-AC27-4DBC-BE49-033EE4EB8ECF
P2860
Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nerve growth factor gene thera ...... pathy in type 1 diabetic mice.
@en
Nerve growth factor gene thera ...... pathy in type 1 diabetic mice.
@nl
type
label
Nerve growth factor gene thera ...... pathy in type 1 diabetic mice.
@en
Nerve growth factor gene thera ...... pathy in type 1 diabetic mice.
@nl
prefLabel
Nerve growth factor gene thera ...... pathy in type 1 diabetic mice.
@en
Nerve growth factor gene thera ...... pathy in type 1 diabetic mice.
@nl
P2093
P2860
P50
P356
P1433
P1476
Nerve growth factor gene thera ...... pathy in type 1 diabetic mice.
@en
P2093
Andrea Caporali
Betty Descamps
Costanza Emanueli
Lorena Zentilin
P2860
P304
P356
10.2337/DB11-0763
P407
P577
2012-01-01T00:00:00Z